Details for New Drug Application (NDA): 020985
✉ Email this page to a colleague
The generic ingredient in CARAC is fluorouracil. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
Summary for 020985
Tradename: | CARAC |
Applicant: | Extrovis |
Ingredient: | fluorouracil |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020985
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 0.5% | ||||
Approval Date: | Oct 27, 2000 | TE: | RLD: | Yes |
Expired US Patents for NDA 020985
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Extrovis | CARAC | fluorouracil | CREAM;TOPICAL | 020985-001 | Oct 27, 2000 | ⤷ Try for Free | ⤷ Try for Free |
Extrovis | CARAC | fluorouracil | CREAM;TOPICAL | 020985-001 | Oct 27, 2000 | ⤷ Try for Free | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription